<html>

<head>   <meta charset="utf-8" />
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 10 (filtered)">
<title>N�ropatik a&#287;r&#305;n&#305;n tedavisinde kullan&#305;lan ila�lar</title>

<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";}
@page Section1
	{size:595.3pt 841.9pt;
	margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.Section1
	{page:Section1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=MsoNormal align=center style='text-align:center;border:none;
padding:0cm'><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;border:none;
padding:0cm'><b><span lang=TR style='font-family:Tahoma'>N�ROPAT&#304;K
A&#286;RI</span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:150%;border:none;
padding:0cm'><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

</div>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>N�ropatik a&#287;r&#305;, santral veya periferik
sinir sistemindeki primer lezyonlara veya disfonksiyona ba&#287;l&#305; olarak
ortaya �&#305;kan a&#287;r&#305; t�r�d�r. N�ropatik a&#287;r&#305;, dokulardaki
hasarla ortaya �&#305;kan nosiseptif a&#287;r&#305;dan farkl&#305; olarak,
s�rekli bir uyarana ihtiya� g�stermez. A&#287;r&#305;y&#305; ba&#351;latan
etken� periferik sinir travmas&#305;, metabolik, inflamatuvar ve di&#287;er
etyolojik fakt�rlere ba&#287;l&#305; olu&#351;abilece&#287;i gibi benzer
etyolojilere ba&#287;l&#305; santral nedenlerden de kaynaklanabilir. V��cu�dun
her�han�gi bir ye�rin�de or�ta�ya �&#305;�kan n��ro�pa�tik a&#287;�r&#305; pe�ri�fe�rik
si�nir sis�te�mi, sant�ral si�nir sis�te�mi ve oto�nom si�nir sis�te�min�den
kay�nak�la�na�bi�lir. </span><span lang=ES style='font-family:Tahoma'>Oto�no�m
si�nir sis�te�mi de n��ro�pa�tik a&#287;�r&#305;�da yay�g&#305;n ola�rak rol oy�na�mak�ta�d&#305;r.
Oto�nom si�nir sis�te�min�den kay�nak�la�nan n��ro�pa�tik a&#287;�r&#305;�lar <i>komp�leks
b�lgesel a&#287;�r&#305; send�rom�la�r&#305; </i>ad&#305;� al�t&#305;n�da in�ce�len�mek�te�dir.
Sonu� olarak, al�t&#305;n�da oto�no�mik �zel�lik�ler ol�sun ol�ma�s&#305;n si�nir
sis�te�min�den kay�nak�la�nan a&#287;�r&#305;�lar n��ro�pa�tik a&#287;�r&#305;
ad&#305; al�t&#305;n�da top�lan�mak�ta�d&#305;r. </span><span lang=TR
style='font-family:Tahoma'>N�ropatik a&#287;r&#305; hasardan veya olu&#351;an
hasar&#305;n &#351;iddetinden ba&#287;&#305;ms&#305;z olarak devam edebilir ve
hatta haftalar, aylar, y&#305;llar i�inde &#351;iddetlenebilir.
A&#287;r&#305;n&#305;n yanl&#305;&#351; tan&#305;mlanmas&#305;, yanl&#305;&#351;
lokalize edilmesi, alg&#305;laman&#305;n gecikmesi ve yay&#305;lma s�z
konusudur. </span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>N�ropatik a&#287;r&#305;n&#305;n olu&#351;umunda rol
oynayan mekanizmalar <i>periferik ve santral</i> <i>mekanizmalar</i> olarak iki
grupta de&#287;erlendirilebilir. Periferik mekanizmalar i�erisinde <i>periferik
sensitizasyon</i> (cerrahi giri&#351;im veya travmadan sonra haraplanan h�crelerden
salg&#305;lanan maddelerin yine baz&#305; ara maddelerle birlikte C liflerini
aktive etmesi ve P maddesinin salg&#305;lanmas&#305;), <i>ektopik
de&#351;arjlar</i> (herhangi bir etyolojiye ba&#287;l&#305; olarak geli&#351;en
sinir hasar&#305; sonras&#305; akson boyunca ektopik uyar&#305;lar&#305;n
olu&#351;mas&#305;), <i>aksonlar aras&#305; anormal etkile&#351;im</i>, <i>katekolaminlere
kar&#351;&#305; artm&#305;&#351; duyarl&#305;l&#305;k</i> gibi etkenler
say&#305;labilir. Santral mekanizmalar ise <i>duyusal yollar&#305;n veya
sempatik sistemin irritasyonu, hipotalamik bozukluk, inen inhibit�r
mekanizmalar&#305;n disfonksiyonu ve �&#305;kan yollar&#305;n
a&#351;&#305;r&#305; aktivasyonu</i> olarak say&#305;labilir.� </span></p>

<p class=MsoNormal style='text-indent:14.15pt'><b><span lang=ES
style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=ES style='font-family:Tahoma'>Periferik sinir
sisteminden kaynaklanan n�ropatik a&#287;r&#305;lar:</span></b></p>

<p class=MsoNormal style='text-indent:14.15pt;line-height:7.0pt'><b><span
lang=ES style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Periferik sinire ait t�m�rler</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Si�nir bas&#305;s&#305;</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=ES style='font-family:
Tahoma'>- Si�nir ezil�me�si, av�l�si�yo�nu, ge�ril�mesi, ke�sil�mesi</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- N��ro�pa�ti�ler (di�abe�tik n��ro�pa�ti, rad�yas�yon
n��ro�pa�ti�si, al�kol n��ro�pa�ti�si, vask�litik n��ro�pa�ti gibi)</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify'><b><span lang=NO-BOK
style='font-family:Tahoma'>Santral sinir sisteminden kaynaklanan n�ropatik
a&#287;r&#305;lar:</span></b></p>

<p class=MsoNormal style='text-indent:14.15pt;line-height:7.0pt'><b><span
lang=NO-BOK style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- Medulla spi�nalis hastal&#305;klar&#305; (kon�t�z�yon,
is�ke�mi, t��m�r)</span></p>

<p class=MsoNormal style='text-align:justify'><span lang=NO-BOK
style='font-family:Tahoma'>- Be�yin sa�p&#305;, ta�la�musu etkileyen patolojik
durumlar (in�farkt, t��m�r, trav�ma)</span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>N�ROPAT&#304;K A&#286;RI
TEDAV&#304;S&#304;NDE KULLANILAN AJANLAR </span></b></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal style='text-align:justify;line-height:150%'><span lang=TR
style='font-family:Tahoma'>N�ropatik a&#287;r&#305;n&#305;n tedavisinde kullan&#305;lan
ajanlar aras&#305;nda ba&#351;l&#305;ca antikonv�lzanlar, trisiklik antidepresanlar,
opioid analjezikler, antiaritmikler, lokal anestezikler say&#305;labilir.
A&#351;a&#287;&#305;da� a&#287;r&#305;l&#305; duruma g�re se�ilmesi gereken ila�lar
�zetlenmi&#351;tir: </span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=503
 style='width:377.2pt;border:solid windowtext 1.0pt'>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><b><span lang=TR style='font-family:Tahoma;color:black'>A&#287;r&#305;l&#305;
  durum</span></b></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span lang=TR
  style='font-family:Tahoma;color:black'>&#304;lk s&#305;ra tedavi</span></b></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;background:
  #D9D9D9;padding:0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span lang=TR
  style='font-family:Tahoma;color:black'>2./3. s&#305;ra tedavi</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>A&#287;r&#305;l&#305;
  N�ropati</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>TSA</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Lamotrijin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>SNRI</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Tramadol</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Postherpetik</span></p>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Nevralji</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Topikal Lidokain</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>TSA</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Kapsaisin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Tramadol</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Valproat</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Trigeminal
  Nevralji</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Okskarbazepin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Karbamazepin</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Cerrahi</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=165 style='width:123.75pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Santral
  A&#287;r&#305;</span></p>
  </td>
  <td width=168 style='width:126.0pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Amitriptilin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Gabapentin </span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Pregabalin</span></p>
  </td>
  <td width=170 style='width:127.45pt;border:solid windowtext 1.0pt;padding:
  0cm 0cm 0cm 0cm;height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Kannabinoidler</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Lamotrijin</span></p>
  <p class=MsoNormal align=center style='text-align:center'><span lang=TR
  style='font-family:Tahoma'>Opioidler</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>TSA: trisiklik antidepresan;
SNRI: Serotonin-noradrenalin geri al&#305;n&#305;m inhibit�rleri</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal style='margin-left:17.85pt;line-height:150%'><b><span
lang=TR style='font-family:Tahoma'>1- ANT&#304;EP&#304;LEPT&#304;KLER:</span></b></p>

<p class=MsoNormal style='margin-left:17.85pt;text-align:justify;line-height:
150%'><span lang=TR style='font-family:Tahoma'>N�ropatik a&#287;r&#305; tedavisinde
kullan&#305;lan antiepileptik ila�lar aras&#305;nda <b>karbamazepin, okskarbazepin</b>,
<b>lamotrijin</b>, <b>gabapentin ve pregabalin </b>say&#305;labilir. Antiepileptikler
n�ronal membranlar&#305; stabilize ederek, sinaptik inhibisyonu artt&#305;rarak
ya da sinaptik eksitasyonu azaltarak etki g�sterirler. Karbamazepin ve okskarbazepin
voltaja-ba&#287;l&#305; sodyum kanal&#305;� inaktivasyonuna neden olur,
ayr&#305;ca her ikisi de eksitat�r n�rotransmiter sal&#305;n&#305;m&#305;n&#305;
azalt&#305;rlar<b>. Karbamazepinin </b>yan etkisi ve ila� etkile&#351;imleri belirgindir,
otoind�ksiyon yapar. Okskarbazepinin ise yan etkisi daha azd&#305;r. Her iki
ajan diyabetik n�ropati, postherpetik nevralji, trigeminal nevraljide
kullan&#305;labilir. <b>Gabapentin</b> GABA konsantrasyonunu ve non vezik�ler
GABA sal&#305;n&#305;m&#305;n&#305; artt&#305;r&#305;r. Bunu N tipi Ca
kanallar&#305; arac&#305;l&#305;&#287;&#305;yla yapar. <b>Pregabalin </b>ise
voltaja ba&#287;l&#305; Ca kanal mod�lat�r�d�r, n�rotransmiter sal&#305;n&#305;m&#305;n&#305;
azalt&#305;r. Lineer bir farmakokineti&#287;e sahiptir, 1-3 g�nde etkisi
ba&#351;lar, %90�a yak&#305;n bio-yararlan&#305;m s�z konusudur. Renal
disfonksiyon varl&#305;&#287;&#305;nda doz ayar&#305; gerekebilir. Son
y&#305;llarda n�ropatik a&#287;r&#305;da ilk s&#305;rada tercih edilen ajan
haline gelmi&#351;tir. Trisiklik antidepresanlar, gabapentin ve di&#287;er
tedavilere (SSRI (selektif</span><span lang=TR style='font-family:Tahoma'> serotonin
geri al&#305;n&#305;m inhibit�rleri), SNRI (Serotonin-noradrenalin geri
al&#305;n&#305;m inhibit�rleri), opioidler gibi) yetersiz yan&#305;t veren
hastalar&#305;n a&#287;r&#305; skorlar&#305;n&#305; anlaml&#305; derecede
d�zeltti&#287;i g�r�lm�&#351;t�r.<i> </i></span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>2-
ANT&#304;DEPRESANLAR� </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Trisiklik-</span></b><i><span
     lang=TR style='font-family:Tahoma'>Amitriptilin </span></i></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Y�ksek dozlarda
etkilidir ve etki doza ba&#287;&#305;ml&#305;d&#305;r. S�rekli ve bat&#305;c&#305;
a&#287;r&#305;da etkilidir. &#304;skemik kalp hastalar&#305;nda ani aritmiye
yol a�&#305;p �l�me neden olabilir, bu nedenle �zellikle ya&#351;l&#305; ve kardiyak
sorunu olan hastalarda dikkatli kullan&#305;lmal&#305;d&#305;r. Sedasyona,
a&#287;&#305;z kurulu&#287;una ve kilo art&#305;&#351;&#305;na yol a�abilir.</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><i><span lang=TR
style='font-family:Tahoma'>&nbsp;</span></i></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>SSRI, SNRI </span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>SSRI ve SNRI�lar�
a&#287;r&#305;l&#305; n�ropatide baz&#305; �al&#305;&#351;malarda plasebodan ��st�n
bulunmu&#351;tur. En s&#305;k kullan&#305;lan ajanlar Venlafaksin� (150-300 mg/g�n)
ve Duloksetin�dir (1x60 mg/g�n).</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><i><span lang=TR
style='font-family:Tahoma'>���� </span></i></p>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>3-
OP&#304;O&#304;DLER� </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Tramadol</span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Etkinli&#287;i orta
derecededir. S�rekli a&#287;r&#305; ve allodinide etkilidir. Etkin doz 100-200 mg/g�n
olup, do&#287;rudan bu dozda ba&#351;lanabilir. Bulant&#305;-kusma ve
kab&#305;zl&#305;k gibi yan etkileri k&#305;s&#305;tlay&#305;c&#305; olabilir.</span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Fentanil</span></b><span
     lang=TR style='font-family:Tahoma'> <i>- transdermal flaster 25/50/75/100</i></span></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Etkinli&#287;i y�ksektir
ve tek flaster 3 g�n etkili olabilir. Yineleyen kullan&#305;mlarda
ba&#287;&#305;ml&#305;l&#305;k geli&#351;ebilir. Yan etkileri Tramadol�le
ayn&#305;d&#305;r. </span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>4- ANT&#304;AR&#304;TM&#304;KLER</span></b></p>

<p class=MsoNormal style='margin-left:18.0pt'><b><span lang=TR
style='font-family:Tahoma'>�</span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Lidokain</span></b></li>
</ul>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>Nonspesifik bir Na kanal blokeridir, etkili olabilir fakat oral
verilemez.</span></p>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>&nbsp;</span></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Meksiletin </span></b></li>
</ul>

<p class=MsoNormal style='margin-left:18.0pt'><span lang=TR style='font-family:
Tahoma'>Lidokainin oral analo&#287;udur<b>. </b>Birka� �al&#305;&#351;mada
plasebodan daha iyi sonu� vermi&#351;tir. Kullan&#305;m&#305; yayg&#305;n
de&#287;ildir.</span></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>&nbsp;</span></b></p>

<p class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>5- LOKAL
TEDAV&#304; </span></b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b><span lang=TR style='font-family:Tahoma'>Kapsaisin</span></b></li>
</ul>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>Ac&#305; biberden
t�retilmi&#351; bir alkaloiddir. Duysal n�ronlardan substans P�yi
a�&#305;&#287;a �&#305;kar&#305;p t�keterek ve epidermal sinir liflerini dejerene
ederek etki g�sterir. Lokal yan etkileri olabilir. Zay&#305;f-orta derecede bir
etkinli&#287;e sahiptir ve ancak yard&#305;mc&#305; tedavi y�ntemi olarak
�nerilir.</span><b><span lang=TR style='font-family:Tahoma'>�� </span></b></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

<p class=MsoNormal><span lang=TR style='font-family:Tahoma'>&nbsp;</span></p>

</div>

</body>

</html>
